InterLACE: International Collaboration For A Life Course Approach To Reproductive Health And Chronic Disease Events
Funder
National Health and Medical Research Council
Funding Amount
$495,965.00
Summary
Cardiovascular disease and diabetes are major chronic diseases among women. This world-leading research combines data from 7 international and 3 Australian studies of womenÍs health. We will investigate the relationship of reproductive health, from menarche to menopause, with the risk of Type 2 diabetes and cardiovascular disease in later life. Findings will support the development of policies and preventive health strategies to reduce the risk of these chronic diseases.
Understanding The Influence Of Agricultural Trade Policy On Food Consumption Patterns, Malnutrition, And Chronic Disease In Thailand And Australia
Funder
National Health and Medical Research Council
Funding Amount
$373,963.00
Summary
Trade policy is often developed without consideration of its effects on health. The Association of South-East Asian Nations (ASEAN) and New Zealand are key trading partners of Australia. Thus the ASEAN-Australia-New Zealand Free Trade Agreement (AANZFTA) was established in 2009. This project aims to analyse the effect of the agricultural trade component of the AANZFTA on food consumption patterns, malnutrition, obesity and chronic disease in Thailand and Australia.
Asbestos And Related Diseases In Western Australia
Funder
National Health and Medical Research Council
Funding Amount
$404,727.00
Summary
This project will extend the follow-up of large, well established groups of people who have experienced significant exposure to blue asbestos, either through their jobs or environmentally. Mesothelioma, lung cancer and asbestosis are common among these groups. This study will provide information on the effects of different levels of exposure to blue asbestos. Ways in which these diseases may be prevented through the diet and other lifestyle habits will be closely examined. This project provides ....This project will extend the follow-up of large, well established groups of people who have experienced significant exposure to blue asbestos, either through their jobs or environmentally. Mesothelioma, lung cancer and asbestosis are common among these groups. This study will provide information on the effects of different levels of exposure to blue asbestos. Ways in which these diseases may be prevented through the diet and other lifestyle habits will be closely examined. This project provides important data on the dose-response effects of a known carcinogen. Due to the integrated nature of our already established follow up systems we are in a unique position worldwide to achieve these aims. The dose response relationships between exposure and disease identified by this study will contribute to occupational health and safety exposure standards and compensation policy in Australia. The information on lifestyle factors is appropriate for use in many different health promotion interventions. Ongoing contact with the cohorts is critical to our involvement in collaborative preventative and biological studies.Read moreRead less
Large-scale Epidemiology, Chronic Disease And Disadvantaged Populations: Evidence And Translation
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
Nationally and internationally, we face an increasing burden of chronic disease and health care costs. Health risk factors and premature ill-health are increasingly concentrated in the disadvantaged. A large proportion of the chronic disease burden is preventable through better evidence and implementation. This application is to conduct innovative large-scale research on Indigenous health, chronic disease and the health of disadvantaged populations, including work on implementation of solutions.
MULTICENTRE BRONCHIECTASIS STUDY: A Collaborative And International Study Of Bronchiectasis In Indigenous Children.
Funder
National Health and Medical Research Council
Funding Amount
$1,496,414.00
Summary
Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New ....Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New Zealand Maori or Pacific Islander and Alaskan Native) has been initiated. In Indigenous children, we aim to define the natural history of chronic moist cough (those at risk of developing bronchiectasis) and bronchiectasis, identify the risk factors associated with progression from early-mild disease (chronic moist cough) to bronchiectasis and to define the role of continuous antibiotic treatment in the prevention of recurrent pulmonary infections that are very common in these children. We plan to follow up Aboriginal children aged 12 months to 8 years diagnosed with bronchiectasis or chronic moist cough. For those diagnosed with bronchiectasis, after fully informed consent is obtained from the parent(s), the child will be allocated by chance to one of the 2 treatment regimes: (1) Azithromycin once-week or (2) placebo once-week. Children will receive the medication or the placebo for a period of 24 months. All these children will be clinically seen 2x-year by the study's paediatrician and 2x-year by the research nurse for the duration of the study. By documenting, for the first time, the epidemiology and natural history of children with chronic moist cough and bronchiectasis, the study will provide a much-needed rationale for their management. If we can scientifically show that this is true, that Azithromycin is effective in reducing the number of respiratory infections, this would be an achievable advance in the treatment in the field for these children.Read moreRead less
Leveraging Women’s Health Data Resources To Reduce Chronic Disease Risk And Extend Healthspan
Funder
National Health and Medical Research Council
Funding Amount
$763,845.00
Summary
Chronic diseases, such as osteoporosis and asthma, pose serious risks for Australian women. Reproductive health is central to women’s use of health services across life and is linked with the risk of chronic diseases. This research will build on two decades of linked data in Australia’s leading study of women’s health. It aims to guide development of women’s use of reproductive and maternal health services as an opportunity to prevent chronic diseases and improve long-term health.
A Case Control Study Of Hypertension In The Setting Of Poverty, Overcrowding And Infection.
Funder
National Health and Medical Research Council
Funding Amount
$603,331.00
Summary
It is unclear why chronic diseases are emerging in regions of significant disadvantage, i.e. where people are not overweight, are physically active and relatively young. We aim to identify factors responsible for the development of high blood pressure in a region where there is overcrowding, poverty, and infection. Low cost strategies to modify risk and educate the community can then be developed to prevent the emergence of these diseases.
This project will update the Wittenoom cohorts by tracing cancers and deaths in Australia and Italy. This will improve risk estimates of lung cancer and mesothelioma. In particular we will see if that risk declines with more than 40 years since exposure, in collaboration with Italian colleagues. We will continue developing an interactive community website to act as a support platform, a layman's bridge to medical research knowledge, public health information and an archive of personal stories.
Thai Health-Risk Transition: A National Cohort Study - Phase II
Funder
National Health and Medical Research Council
Funding Amount
$1,662,829.00
Summary
We are conducting a pioneering collaborative longitudinal study of population health in Thailand, following over time more than 80,000 adults living throughout the country. We repeatedly measure a wide array of health risks and outcomes. We capture information on the health-risk transition underway in Thailand as the population experiences the new burden of disease associated with economic development and modernisation. We team up with policy makers for national responses to lower the burden.
Chronic Disease Epidemiology In Different Populations: Risk Factors, Detection And Prevention
Funder
National Health and Medical Research Council
Funding Amount
$621,458.00
Summary
To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases ....To investigate causes, detection and prevention of diabetes, cardiovascular disease, and kidney disease in Aboriginal and international populations, I will maintain a long-term cohort with a 20-year follow-up in Aboriginal people and to analyse several large repeated cross-sectional data collected over 25 years in China. For the next 5 years, I will continue to to provide critical epidemiological evidence for the development of health policies and clinical guidelines related to chronic diseases in different populations.Read moreRead less